Ingenium Therapeutics

Next-gen cancer therapies powered by innate immunity.

founder

Jinok Koh

founded

2020

field

BIO∙Healthcare

"Laplace Partners provides invaluable guidance beyond investment, standing firmly with you through your toughest challenges."

Related Posts

CEO Interview: Jinok Ko of Ingenium Therapeutics

Subscribe

By subscribing, you agree to our Privacy Policy.

KR

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

KR

© 2025 Laplace Partners

Subscribe

By subscribing, you agree to our Privacy Policy.

KR

© 2025 Laplace Partners